BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25395497)

  • 1. The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.
    Peng F; Xia X; He F; Li Z; Huang F; Yu X
    Perit Dial Int; 2015; 35(5):566-75. PubMed ID: 25395497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with Type 2 diabetes mellitus.
    Suo M; Wen D; Wang W; Zhang T
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32352504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study.
    Abe M; Hamano T; Hoshino J; Wada A; Nakai S; Masakane I
    Sci Rep; 2019 Mar; 9(1):3320. PubMed ID: 30824808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
    Rooney MR; Tang O; Pankow JS; Selvin E
    Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis.
    Zhao C; Luo Q; He F; Peng F; Xia X; Huang F; Yu X
    Diabet Med; 2014 Jul; 31(7):813-20. PubMed ID: 24628621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood glucose levels in peritoneal dialysis are better reflected by HbA1c than by glycated albumin.
    Watanabe Y; Ohno Y; Inoue T; Takane H; Okada H; Suzuki H
    Adv Perit Dial; 2014; 30():75-82. PubMed ID: 25338425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical evaluation of the Diazyme glycated serum protein assay on the siemens ADVIA 1800: comparison of results against HbA1c for diagnosis and management of diabetes.
    Rodriguez-Capote K; Tovell K; Holmes D; Dayton J; Higgins TN
    J Diabetes Sci Technol; 2015 Mar; 9(2):192-9. PubMed ID: 25591854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of glycated albumin over glycated haemoglobin as indicator of glycaemic control and predictor of all-cause mortality in patients with type 2 diabetes mellitus receiving peritoneal dialysis.
    Miyabe M; Kurajoh M; Mori K; Okuno S; Okada S; Emoto M; Tsujimoto Y; Inaba M
    Ann Clin Biochem; 2019 Nov; 56(6):684-691. PubMed ID: 31411048
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of diabetes mellitus on peritoneal dialysis: the Turkey Multicenter Clinic Study.
    Ozener C; Arikan H; Karayaylali I; Utas C; Bozfakioglu S; Akpolat T; Ataman R; Ersoy F; Camsari T; Yavuz M; Akcicek F; Yilmaz ME
    Ren Fail; 2014 Mar; 36(2):149-53. PubMed ID: 24131086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis.
    Afghahi H; Nasic S; Peters B; Rydell H; Hadimeri H; Svensson J
    PLoS One; 2022; 17(1):e0262880. PubMed ID: 35077471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea.
    Lee MJ; Kwon YE; Park KS; Kee YK; Yoon CY; Han IM; Han SG; Oh HJ; Park JT; Han SH; Yoo TH; Kim YL; Kim YS; Yang CW; Kim NH; Kang SW
    Medicine (Baltimore); 2016 Mar; 95(11):e3118. PubMed ID: 26986162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
    Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
    Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
    Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
    Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.